摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2S,3S,6S,7R)-7-(ethylsulfanylmethyl)-2,3,6-trihydroxy-3-methyl-5,10-dioxa-11-azatricyclo[5.3.3.01,6]tridecane-12,13-dione | 114944-07-9

中文名称
——
中文别名
——
英文名称
(1S,2S,3S,6S,7R)-7-(ethylsulfanylmethyl)-2,3,6-trihydroxy-3-methyl-5,10-dioxa-11-azatricyclo[5.3.3.01,6]tridecane-12,13-dione
英文别名
——
(1S,2S,3S,6S,7R)-7-(ethylsulfanylmethyl)-2,3,6-trihydroxy-3-methyl-5,10-dioxa-11-azatricyclo[5.3.3.01,6]tridecane-12,13-dione化学式
CAS
114944-07-9
化学式
C14H21NO7S
mdl
——
分子量
347.389
InChiKey
YDRFXUIIBZDZGS-HPCHECBXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.2
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    151
  • 氢给体数:
    4
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酰基-赖氨酰-甲胺(1S,2S,3S,6S,7R)-7-(ethylsulfanylmethyl)-2,3,6-trihydroxy-3-methyl-5,10-dioxa-11-azatricyclo[5.3.3.01,6]tridecane-12,13-dione甲醇 为溶剂, 反应 16.0h, 以51%的产率得到N-((S)-5-Acetylamino-5-methylcarbamoyl-pentyl)-N'-((2S,3S,3aS)-7-ethylsulfanylmethyl-3,7a-dihydroxy-2-hydroxymethyl-2-methyl-hexahydro-furo[3,2-b]pyran-3a-yl)-oxalamide
    参考文献:
    名称:
    Studies on the reactivity of bicyclomycin with nucleophilic amino acid derivatives
    摘要:
    DOI:
    10.1021/jo00277a052
  • 作为产物:
    描述:
    二环霉素乙硫醇sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以46%的产率得到(1S,2S,3S,6S,7R)-7-(ethylsulfanylmethyl)-2,3,6-trihydroxy-3-methyl-5,10-dioxa-11-azatricyclo[5.3.3.01,6]tridecane-12,13-dione
    参考文献:
    名称:
    Chemical, biochemical, and biological studies on select C1 triol modified bicyclomycins
    摘要:
    To determine the importance of the C(1) triol group to bicyclomycin (1)-mediated transformations we prepared the bicyclomycin diastereomers 6 (C(1')-R, C(2')-S) and 7 (C(1')-S, C(2')-R), in which the stereochemical configuration at C(1') and C(2') in the triol group in 1 (C(1')-S, C(2')-S) was reversed, and the C(1') ketone analogue 8 (C(2')-S), in which the stereogenic center at C(1') in 1 was removed. Synthesis of 6 and 8 proceeded from C(1') ketobicyclomycin C(2'), C(3') acetonide (10). Reduction (NaBH4, CeCl3) of 10 produced a diastereomeric mixture, that, after separation and removal of the acetonide protecting group, gave 6. Correspondingly, deprotection of 10 gave 8. Bicyclomycin analogue 7 was prepared by dissolving the known bicyclomycin C(2'), C(3') epoxide (13) in dilute methanolic sulfuric acid; this process produced the novel [O(9)-C(2')]cyclized bicyclomycin (14). Compound 14 formed with inversion of the C(2') center. Subsequent aqueous acid hydrolysis yielded 7. Data documenting the proposed reaction pathways and structures for compounds 6-8 are presented. The stability of bicyclomycin analogues 6-8 and 1 in deuterium oxide (pD 5.6-5.8, 7.4, 9.2-9.4) and in DMF-d(7) solutions were examined. Compounds 7 and 8 were stable under these conditions (room temperature, 14 days), whereas bicyclomycin underwent noticeable change only in basic deuterium oxide. Correspondingly, 6 was rapidly converted (t(1/2) < 30 h) to a new set of products in both acidic and basic deuterium oxide as well as in DMF-d(7). The facility of these conversions have been attributed in part to the role of the C(1) triol substituent in the ring opening of the C(6) hemiketal group in 6. All three bicyclomycin analogues reacted with ethanethiol at the C(5)-C(5a) exomethylene unit at rates comparable to 1 in buffered (''pH'' 8.0-8.5) THF-H2O (3:1) mixtures. The products generated from 6 and 7 were similar to those previously determined for 1, except for the configuration of the C(1') and C(2') substituents, whereas 8 yielded the novel piperidine adduct 33. The ethanethiol-8 reaction proceeded easily in spite of earlier projections that the C(1') hydroxyl group in bicyclomycin was required for exomethylene modification. Similarly the corresponding C(2'), C(3') acetonide of 8, 10, readily underwent reaction with ethanethiol. Significantly, compounds 6 and 7 only partially (25-35%) inhibited rho-dependent hydrolysis of ATP at the concentration levels observed to block ATPase activity by 1, and no inhibition of ATP hydrolysis was detected for 8. Our previous studies established that the primary site of bicyclomycin action in Escherichia coli is the cellular protein transcription termination factor rho. Similarly, none of the three compounds exhibited antibiotic activity at a concentration of 1200 mu g/mL, using a filter disc assay. These cumulative results suggested that key interactions existed between the C(1) triol group in bicyclomycin and the antibiotic binding site in rho, which are necessary for drug utilization and function.
    DOI:
    10.1021/ja00101a001
点击查看最新优质反应信息

文献信息

  • Role of the C(6)-Hydroxy Group in Bicyclomycin:  Synthesis, Structure, and Chemical, Biochemical, and Biological Properties
    作者:Alejandro Santillán,、Xiangdong Zhang、Jon Hardesty、William R. Widger、Kohn
    DOI:10.1021/jm9708386
    日期:1998.3.1
    the C(6) hydroxy group in 1 was essential for activity. We found that replacing the C(6)-hydroxy group in 1 with weaker hydrogen bond donors led to low inhibitory activities in the rho-dependent ATPase and transcription termination assays. None of the bicyclomycin derivatives exhibited antibiotic activity against E. coli W3350 cells at a 32 mg/mL concentration. The apparent specificity for the C(6)-hydroxy
    双环霉素(1)是一种商业抗生素,其在大肠杆菌中的主要作用位点是转录终止因子rho。最近的结构活性关系研究为1,表明用烷氧基和代烷氧基取代基取代C(6)-羟基会导致rho生化分析中抑制活性的急剧下降。这种结构特异性的起源已通过C(6)-基-(13),C(6)-(羟基基)-(14)和C(6)的合成以及化学生物化学生物学评估进行了探索-巯基双环霉素(15)。这些化合物,像1一样,能够与​​rho进入氢键供体相互作用,并且能够进行C(6)开环以生成α,β-不饱和羰基,亚胺酮系统。将13-15的化学反应性与1的化学反应性进行了比较。我们观察到1,在中性和碱性条件下用EtSH处理后,很容易进行C(6)的半胱酸键裂解,然后将共轭物添加到β-亚甲基-α-酮酰胺2中,从而得到迈克尔加成加合物,而13-15通过初始裂解C(1 )-O(2)键。13-15和相关类似物的生化和生物学测定表明1中的C
  • Studies on the reactivity of bicyclomycin with thiols
    作者:Syed Abuzar、Harold Kohn
    DOI:10.1021/ja00164a036
    日期:1990.4
    The chemical reactivity of the clinically important antibiotic bicyclomycin with thiols has been investigated. Emphasis has been placed on discerning the product profiles obtained with cycteine derivatives in light of earlier projections on the likely in vivo biological nucleophile in bicyclomycin-mediated transformations
    已经研究了临床上重要的抗生素双环霉素醇的化学反应性。鉴于早期对双环霉素介导的转化中可能的体内生物亲核试剂的预测,重点放在辨别用半胱酸衍生物获得的产品概况
  • Observations concerning the reactivity of bicyclomycin and bicyclomycin derivatives with organophosphorus reagents
    作者:Marco A. Vela、Harold Kohn
    DOI:10.1021/jo00050a055
    日期:1992.11
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺